Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Corticosteroids superior to IVIG in MIS-C myocardial damage due to COVID-19
Treatment with corticosteroids (CS) among children with multisystem inflammatory syndrome (MIS-C) cardiovascular involvement temporarily associated with COVID-19 leads to faster normalization of left ventricular ejection fraction (LVEF), fever, improved laboratory analysis, and shorter intensive care unit stay than treatment with intravenous immunoglobulin (IVIG), a study has shown.
Corticosteroids superior to IVIG in MIS-C myocardial damage due to COVID-19
22 Oct 2021
Bimekizumab maintains skin clearance in patients with plaque psoriasis
Maintenance treatment with bimekizumab achieves complete scalp, palmoplantar, or nail clearance in patients with moderate-to-severe plaque psoriasis, according to two phase III trials presented at EADV 2021.
Bimekizumab maintains skin clearance in patients with plaque psoriasis
22 Oct 2021
Baricitinib + standard care may reduce mortality in hospitalized COVID-19 patients
The oral selective Janus kinase 1/2 inhibitor baricitinib, when added to standard of care (SoC), reduced the risk of mortality among adults hospitalized with COVID-19. However, the primary outcome of disease progression was not met in the baricitinib group, results of the phase III COV-BARRIER study showed.
Baricitinib + standard care may reduce mortality in hospitalized COVID-19 patients
21 Oct 2021
SGLT2i alone or with DPP4 inhibitors prevents hospitalization due to heart failure
Use of sodium glucose co-transporter 2 inhibitors (SGLT2is) either alone or in combination with dipeptidyl peptidase 4 inhibitors (DPP4is) reduces the risk of hospitalization from heart failure (HHF), a study has shown. In contrast, thiazolidinediones alone or in combination with DPP4is increases HHF risk, but glucose-lowering can help reduce HHF.
